Abstract
This case report describes a patient with esophageal carcinoma and tumor-associated gastroparesis. The radionuclide gastric emptying study diagnosed very delayed liquid and solid gastric emptying. Metoclopramide was administered intravenously during the study and was able to predict a good response to oral therapy.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1132-1134 |
| Number of pages | 3 |
| Journal | Digestive Diseases and Sciences |
| Volume | 34 |
| Issue number | 7 |
| DOIs | |
| State | Published - Jul 1989 |
Keywords
- esophageal carcinoma
- gastric emptying
- gastroparesis
- metoclopramide
- radionuclide
ASJC Scopus subject areas
- Physiology
- Gastroenterology
Fingerprint
Dive into the research topics of 'Tumor-associated gastroparesis with esophageal carcinoma - Use of intravenous metoclopramide during radionuclide gastric emptying studies to predict clinical response'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS